1 Primary Hepatocytes Market Overview
1.1 Product Overview and Scope of Primary Hepatocytes
1.2 Primary Hepatocytes Segment by Type
1.2.1 Global Primary Hepatocytes Market Value Comparison by Type (2023-2029)
1.2.2 Human Primary Cells
1.2.3 Animal Primary Cells
1.3 Primary Hepatocytes Segment by Application
1.3.1 Global Primary Hepatocytes Market Value by Application: (2023-2029)
1.3.2 Life Science Research Companies
1.3.3 Research Institutes
1.3.4 Others
1.4 Global Primary Hepatocytes Market Size Estimates and Forecasts
1.4.1 Global Primary Hepatocytes Revenue 2018-2029
1.4.2 Global Primary Hepatocytes Sales 2018-2029
1.4.3 Global Primary Hepatocytes Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Primary Hepatocytes Market Competition by Manufacturers
2.1 Global Primary Hepatocytes Sales Market Share by Manufacturers (2018-2023)
2.2 Global Primary Hepatocytes Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Primary Hepatocytes Average Price by Manufacturers (2018-2023)
2.4 Global Primary Hepatocytes Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Primary Hepatocytes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Primary Hepatocytes, Product Type & Application
2.7 Primary Hepatocytes Market Competitive Situation and Trends
2.7.1 Primary Hepatocytes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Primary Hepatocytes Players Market Share by Revenue
2.7.3 Global Primary Hepatocytes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Primary Hepatocytes Retrospective Market Scenario by Region
3.1 Global Primary Hepatocytes Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Primary Hepatocytes Global Primary Hepatocytes Sales by Region: 2018-2029
3.2.1 Global Primary Hepatocytes Sales by Region: 2018-2023
3.2.2 Global Primary Hepatocytes Sales by Region: 2024-2029
3.3 Global Primary Hepatocytes Global Primary Hepatocytes Revenue by Region: 2018-2029
3.3.1 Global Primary Hepatocytes Revenue by Region: 2018-2023
3.3.2 Global Primary Hepatocytes Revenue by Region: 2024-2029
3.4 North America Primary Hepatocytes Market Facts & Figures by Country
3.4.1 North America Primary Hepatocytes Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Primary Hepatocytes Sales by Country (2018-2029)
3.4.3 North America Primary Hepatocytes Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Primary Hepatocytes Market Facts & Figures by Country
3.5.1 Europe Primary Hepatocytes Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Primary Hepatocytes Sales by Country (2018-2029)
3.5.3 Europe Primary Hepatocytes Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Primary Hepatocytes Market Facts & Figures by Country
3.6.1 Asia Pacific Primary Hepatocytes Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Primary Hepatocytes Sales by Country (2018-2029)
3.6.3 Asia Pacific Primary Hepatocytes Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Primary Hepatocytes Market Facts & Figures by Country
3.7.1 Latin America Primary Hepatocytes Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Primary Hepatocytes Sales by Country (2018-2029)
3.7.3 Latin America Primary Hepatocytes Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Primary Hepatocytes Market Facts & Figures by Country
3.8.1 Middle East and Africa Primary Hepatocytes Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Primary Hepatocytes Sales by Country (2018-2029)
3.8.3 Middle East and Africa Primary Hepatocytes Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Primary Hepatocytes Sales by Type (2018-2029)
4.1.1 Global Primary Hepatocytes Sales by Type (2018-2023)
4.1.2 Global Primary Hepatocytes Sales by Type (2024-2029)
4.1.3 Global Primary Hepatocytes Sales Market Share by Type (2018-2029)
4.2 Global Primary Hepatocytes Revenue by Type (2018-2029)
4.2.1 Global Primary Hepatocytes Revenue by Type (2018-2023)
4.2.2 Global Primary Hepatocytes Revenue by Type (2024-2029)
4.2.3 Global Primary Hepatocytes Revenue Market Share by Type (2018-2029)
4.3 Global Primary Hepatocytes Price by Type (2018-2029)
5 Segment by Application
5.1 Global Primary Hepatocytes Sales by Application (2018-2029)
5.1.1 Global Primary Hepatocytes Sales by Application (2018-2023)
5.1.2 Global Primary Hepatocytes Sales by Application (2024-2029)
5.1.3 Global Primary Hepatocytes Sales Market Share by Application (2018-2029)
5.2 Global Primary Hepatocytes Revenue by Application (2018-2029)
5.2.1 Global Primary Hepatocytes Revenue by Application (2018-2023)
5.2.2 Global Primary Hepatocytes Revenue by Application (2024-2029)
5.2.3 Global Primary Hepatocytes Revenue Market Share by Application (2018-2029)
5.3 Global Primary Hepatocytes Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific, Inc.
6.1.1 Thermo Fisher Scientific, Inc. Corporation Information
6.1.2 Thermo Fisher Scientific, Inc. Description and Business Overview
6.1.3 Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Scientific, Inc. Primary Hepatocytes Product Portfolio
6.1.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.2 Merck KGaA
6.2.1 Merck KGaA Corporation Information
6.2.2 Merck KGaA Description and Business Overview
6.2.3 Merck KGaA Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck KGaA Primary Hepatocytes Product Portfolio
6.2.5 Merck KGaA Recent Developments/Updates
6.3 Lonza
6.3.1 Lonza Corporation Information
6.3.2 Lonza Description and Business Overview
6.3.3 Lonza Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Lonza Primary Hepatocytes Product Portfolio
6.3.5 Lonza Recent Developments/Updates
6.4 Cell Biologics, Inc.
6.4.1 Cell Biologics, Inc. Corporation Information
6.4.2 Cell Biologics, Inc. Description and Business Overview
6.4.3 Cell Biologics, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cell Biologics, Inc. Primary Hepatocytes Product Portfolio
6.4.5 Cell Biologics, Inc. Recent Developments/Updates
6.5 PromoCell GmbH
6.5.1 PromoCell GmbH Corporation Information
6.5.2 PromoCell GmbH Description and Business Overview
6.5.3 PromoCell GmbH Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.5.4 PromoCell GmbH Primary Hepatocytes Product Portfolio
6.5.5 PromoCell GmbH Recent Developments/Updates
6.6 HemaCare Corporation
6.6.1 HemaCare Corporation Corporation Information
6.6.2 HemaCare Corporation Description and Business Overview
6.6.3 HemaCare Corporation Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.6.4 HemaCare Corporation Primary Hepatocytes Product Portfolio
6.6.5 HemaCare Corporation Recent Developments/Updates
6.7 ZenBio, Inc.
6.6.1 ZenBio, Inc. Corporation Information
6.6.2 ZenBio, Inc. Description and Business Overview
6.6.3 ZenBio, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ZenBio, Inc. Primary Hepatocytes Product Portfolio
6.7.5 ZenBio, Inc. Recent Developments/Updates
6.8 STEMCELL Technologies, Inc.
6.8.1 STEMCELL Technologies, Inc. Corporation Information
6.8.2 STEMCELL Technologies, Inc. Description and Business Overview
6.8.3 STEMCELL Technologies, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.8.4 STEMCELL Technologies, Inc. Primary Hepatocytes Product Portfolio
6.8.5 STEMCELL Technologies, Inc. Recent Developments/Updates
6.9 Corning Incorporated
6.9.1 Corning Incorporated Corporation Information
6.9.2 Corning Incorporated Description and Business Overview
6.9.3 Corning Incorporated Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Corning Incorporated Primary Hepatocytes Product Portfolio
6.9.5 Corning Incorporated Recent Developments/Updates
6.10 AllCells
6.10.1 AllCells Corporation Information
6.10.2 AllCells Description and Business Overview
6.10.3 AllCells Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AllCells Primary Hepatocytes Product Portfolio
6.10.5 AllCells Recent Developments/Updates
6.11 Axol Bioscience Ltd.
6.11.1 Axol Bioscience Ltd. Corporation Information
6.11.2 Axol Bioscience Ltd. Primary Hepatocytes Description and Business Overview
6.11.3 Axol Bioscience Ltd. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Axol Bioscience Ltd. Primary Hepatocytes Product Portfolio
6.11.5 Axol Bioscience Ltd. Recent Developments/Updates
6.12 iXCells Biotechnologies
6.12.1 iXCells Biotechnologies Corporation Information
6.12.2 iXCells Biotechnologies Primary Hepatocytes Description and Business Overview
6.12.3 iXCells Biotechnologies Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.12.4 iXCells Biotechnologies Primary Hepatocytes Product Portfolio
6.12.5 iXCells Biotechnologies Recent Developments/Updates
6.13 Neuromics
6.13.1 Neuromics Corporation Information
6.13.2 Neuromics Primary Hepatocytes Description and Business Overview
6.13.3 Neuromics Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Neuromics Primary Hepatocytes Product Portfolio
6.13.5 Neuromics Recent Developments/Updates
6.14 StemExpress
6.14.1 StemExpress Corporation Information
6.14.2 StemExpress Primary Hepatocytes Description and Business Overview
6.14.3 StemExpress Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.14.4 StemExpress Primary Hepatocytes Product Portfolio
6.14.5 StemExpress Recent Developments/Updates
6.15 BioIVT
6.15.1 BioIVT Corporation Information
6.15.2 BioIVT Primary Hepatocytes Description and Business Overview
6.15.3 BioIVT Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.15.4 BioIVT Primary Hepatocytes Product Portfolio
6.15.5 BioIVT Recent Developments/Updates
6.16 ScienCell Research Laboratories, Inc.
6.16.1 ScienCell Research Laboratories, Inc. Corporation Information
6.16.2 ScienCell Research Laboratories, Inc. Primary Hepatocytes Description and Business Overview
6.16.3 ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.16.4 ScienCell Research Laboratories, Inc. Primary Hepatocytes Product Portfolio
6.16.5 ScienCell Research Laboratories, Inc. Recent Developments/Updates
6.17 PPA Research Group, Inc.
6.17.1 PPA Research Group, Inc. Corporation Information
6.17.2 PPA Research Group, Inc. Primary Hepatocytes Description and Business Overview
6.17.3 PPA Research Group, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.17.4 PPA Research Group, Inc. Primary Hepatocytes Product Portfolio
6.17.5 PPA Research Group, Inc. Recent Developments/Updates
6.18 Creative Bioarray
6.18.1 Creative Bioarray Corporation Information
6.18.2 Creative Bioarray Primary Hepatocytes Description and Business Overview
6.18.3 Creative Bioarray Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Creative Bioarray Primary Hepatocytes Product Portfolio
6.18.5 Creative Bioarray Recent Developments/Updates
6.19 BPS Bioscience, Inc.
6.19.1 BPS Bioscience, Inc. Corporation Information
6.19.2 BPS Bioscience, Inc. Primary Hepatocytes Description and Business Overview
6.19.3 BPS Bioscience, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.19.4 BPS Bioscience, Inc. Primary Hepatocytes Product Portfolio
6.19.5 BPS Bioscience, Inc. Recent Developments/Updates
6.20 Epithelix Sàrl
6.20.1 Epithelix Sàrl Corporation Information
6.20.2 Epithelix Sàrl Primary Hepatocytes Description and Business Overview
6.20.3 Epithelix Sàrl Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Epithelix Sàrl Primary Hepatocytes Product Portfolio
6.20.5 Epithelix Sàrl Recent Developments/Updates
6.21 ReachBio LLC
6.21.1 ReachBio LLC Corporation Information
6.21.2 ReachBio LLC Primary Hepatocytes Description and Business Overview
6.21.3 ReachBio LLC Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.21.4 ReachBio LLC Primary Hepatocytes Product Portfolio
6.21.5 ReachBio LLC Recent Developments/Updates
6.22 AcceGen
6.22.1 AcceGen Corporation Information
6.22.2 AcceGen Primary Hepatocytes Description and Business Overview
6.22.3 AcceGen Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.22.4 AcceGen Primary Hepatocytes Product Portfolio
6.22.5 AcceGen Recent Developments/Updates
6.23 Sekisui XenoTech, LLC
6.23.1 Sekisui XenoTech, LLC Corporation Information
6.23.2 Sekisui XenoTech, LLC Primary Hepatocytes Description and Business Overview
6.23.3 Sekisui XenoTech, LLC Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Sekisui XenoTech, LLC Primary Hepatocytes Product Portfolio
6.23.5 Sekisui XenoTech, LLC Recent Developments/Updates
6.24 Biopredic International
6.24.1 Biopredic International Corporation Information
6.24.2 Biopredic International Primary Hepatocytes Description and Business Overview
6.24.3 Biopredic International Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Biopredic International Primary Hepatocytes Product Portfolio
6.24.5 Biopredic International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Primary Hepatocytes Industry Chain Analysis
7.2 Primary Hepatocytes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Primary Hepatocytes Production Mode & Process
7.4 Primary Hepatocytes Sales and Marketing
7.4.1 Primary Hepatocytes Sales Channels
7.4.2 Primary Hepatocytes Distributors
7.5 Primary Hepatocytes Customers
8 Primary Hepatocytes Market Dynamics
8.1 Primary Hepatocytes Industry Trends
8.2 Primary Hepatocytes Market Drivers
8.3 Primary Hepatocytes Market Challenges
8.4 Primary Hepatocytes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer